Yahoo Web Search

  1. MIAMI, Sept. 19, 2018 /PRNewswire/ -- A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at ...

  2. By John Miller ZURICH, Sept 21 (Reuters) - A European Medicines Agency panel recommended approval of Spark Therapeutics' gene therapy for blindness, a move that also boosts Swiss ...

  3. Luxturna was developed and is marketed in the US by Spark Therapeutics. If approved, voretigene neparvovec will be...

  4. (GLOBE NEWSWIRE via COMTEX) -- Novartis International AG / Novartis announces positive CHMP opinion for one-time gene therapy Luxturna(R) to treat children and adults with rare ...

  5. Nature's 10

    Nature2 hours ago

    A biologist developed gene-editing tools that are new to nature, and that could one day save lives. When David Liu was an undergraduate student 25 years ago, he wrote a dissertation that ...

  6. The results of the trials “Gene Therapy in Patients with Transfusion-Dependentβ-Thalassemia,” are published today in the New England Journal of Medicine (NEJM).

  7. A final decision on Luxturna's use in the European Union is expected within the next two months

  8. BlueRock Therapeutics, a biotech company looking to create cell and gene therapies in the field of regenerative medicine, just appointed former investment banker Shane Kovacs as its new ...

  9. Krystal Biotech: Buy The Dip

    Seeking Alpha11 hours ago

    Shares of Krystal Biotech (KRYS) have risen by 65% since I did further due diligence on this gene therapy name as a result of a reader inquiry. On the other hand, the stock price ...

  10. Raymond James analyst Steven Seedhouse said the gene-editing pioneer that’s among the year’s hottest biotech stocks appears “crispy and overcooked,” assigning the company its first sell-equivalent ...

  1. 12345234 results